|
|
|
Corporate Profile: Echo Therapeutics
| Summary: |
Echo Therapeutics is focused on the development and commercialization of a non-invasive (needle-free) and wireless transdermal continuous glucose monitoring (tCGM) system for diabetic patients.
|
| Address (HQ): |
8 Penn Center
1628 JFK Boulevard
Suite 300
Philadelphia, PA 19103 |
| Phone #'s (HQ): |
| Main |
(215) 717-4100 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| ECTE |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
